<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">24499278</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>02</Month>
            <Day>06</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>02</Month>
            <Day>06</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2014</Year>
            <Month>05</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">1710-1484</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2013</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology</Title>
                <ISOAbbreviation>Allergy Asthma Clin Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions.</ArticleTitle>
            <Pagination>
                <MedlinePgn>42</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1710-1492-9-42</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several different criteria for the positivity of the flow-assisted Basophil Activation Test (BAT) for the diagnosis of Neuromuscular Blocking Agents (NMBA) hypersensitivity reactions have been used in past studies. Our aims were to determine the threshold for BAT positivity expressed as the stimulation index (SI, calculated as the percentage of activated basophils after stimulation with NMBA divided by the number of basophils with no NMBA stimulation) and as the percentage of activated basophils, and to determine the sensitivity and specificity of BAT for NMBAs.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">22 consenting adult patients with previous intraanaesthetic NMBAs-related hypersensitivity reactions were tested for the culprit drug. 34 controls who tolerated NMBAs were similarly tested. BAT was performed using Flow2Cast technique and the up-regulation of the CD63 marker on the basophils was measured using Cell Quest programme (FACSCalibur Becton Dickinson, USA). Receiver operating characteristics curve (ROC) analysis was performed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">ROC curve analysis for BAT results versus history yields a stimulation index of 1.76 as the optimal threshold, with an AUC of 0.81 (CI 95% 0.69-0.93, p??&lt;??0.01) and a percentage of activated basophils??&gt;??5.01%, with an AUC of 0.84 (CI 95% 0.72-0.95, p??&lt;??0.01). Considering both thresholds (the SI?‰â‰¥??1.76 together with the percentage of activated basophils??&gt;??5%) as diagnostic criteria, 15 patients had positive BAT, the overall BAT sensitivity being 68.18% (CI 95% 45.11-82.26%). None of the controls fulfilled both criteria and the specificity of the test was 100% (CI 95% 87.35-100%).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">With a stimulation index ?‰¥??1.76 and a percentage of activated basophils??&gt;??5.01% as threshold, the performance of BAT for NMBAs yields 68.18% sensitivity and 100% specificity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hagau</LastName>
                    <ForeName>Natalia</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Anaesthesia and Intensive Care, University of Medicine and Pharmacy &quot;Iuliu Hatieganu&quot;, Cluj-Napoca, Romania. hagaunatalia@gmail.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gherman-Ionica</LastName>
                    <ForeName>Nadia</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sfichi</LastName>
                    <ForeName>Manuela</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petrisor</LastName>
                    <ForeName>Cristina</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Allergy Asthma Clin Immunol</MedlineTA>
            <NlmUniqueID>101244313</NlmUniqueID>
            <ISSNLinking>1710-1484</ISSNLinking>
        </MedlineJournalInfo>
        <OtherID Source="NLM">PMC4029498</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>8</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1710-1492-9-42</ArticleId>
            <ArticleId IdType="doi">10.1186/1710-1492-9-42</ArticleId>
            <ArticleId IdType="pubmed">24499278</ArticleId>
            <ArticleId IdType="pmc">PMC4029498</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
